CHAPTER 5: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Liver Cancer
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Lung Cancer
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Breast Cancer
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Prostate Cancer
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Kidney Cancer
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 Bone Metastasis
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
5.8 Other Cancers
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market analysis by country
CHAPTER 7: INTERVENTIONAL ONCOLOGY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Cancer Type
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product Type
7.2.5.1.2 Market size and forecast, by Cancer Type
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product Type
7.2.5.2.2 Market size and forecast, by Cancer Type
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product Type
7.2.5.3.2 Market size and forecast, by Cancer Type
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Cancer Type
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product Type
7.3.5.1.2 Market size and forecast, by Cancer Type
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 U.K.
7.3.5.2.1 Market size and forecast, by Product Type
7.3.5.2.2 Market size and forecast, by Cancer Type
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 France
7.3.5.3.1 Market size and forecast, by Product Type
7.3.5.3.2 Market size and forecast, by Cancer Type
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Spain
7.3.5.4.1 Market size and forecast, by Product Type
7.3.5.4.2 Market size and forecast, by Cancer Type
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Italy
7.3.5.5.1 Market size and forecast, by Product Type
7.3.5.5.2 Market size and forecast, by Cancer Type
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product Type
7.3.5.6.2 Market size and forecast, by Cancer Type
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Cancer Type
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product Type
7.4.5.1.2 Market size and forecast, by Cancer Type
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product Type
7.4.5.2.2 Market size and forecast, by Cancer Type
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product Type
7.4.5.3.2 Market size and forecast, by Cancer Type
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Product Type
7.4.5.4.2 Market size and forecast, by Cancer Type
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Australia
7.4.5.5.1 Market size and forecast, by Product Type
7.4.5.5.2 Market size and forecast, by Cancer Type
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Product Type
7.4.5.6.2 Market size and forecast, by Cancer Type
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Cancer Type
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product Type
7.5.5.1.2 Market size and forecast, by Cancer Type
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product Type
7.5.5.2.2 Market size and forecast, by Cancer Type
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product Type
7.5.5.3.2 Market size and forecast, by Cancer Type
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product Type
7.5.5.4.2 Market size and forecast, by Cancer Type
7.5.5.4.3 Market size and forecast, by End User
List of Tables
Table 1. Global Interventional Oncology Market, by Product Type, 2021-2030,($Million)
Table 2. Interventional Oncology Market Revenue, for Embolization Devices, by Region , 2021-2030,($Million)
Table 3. Interventional Oncology Market Embolization Devices by Country, 2021-2030,($Million)
Table 4. Interventional Oncology Market Revenue, for Ablation Devices, by Region , 2021-2030,($Million)
Table 5. Interventional Oncology Market Ablation Devices by Country, 2021-2030,($Million)
Table 6. Interventional Oncology Market Revenue, for Support Devices, by Region , 2021-2030,($Million)
Table 7. Interventional Oncology Market Support Devices by Country, 2021-2030,($Million)
Table 8. Global Interventional Oncology Market, by Cancer Type, 2021-2030,($Million)
Table 9. Interventional Oncology Market Revenue, for Liver Cancer, by Region , 2021-2030,($Million)
Table 10. Interventional Oncology Market Liver Cancer by Country, 2021-2030,($Million)
Table 11. Interventional Oncology Market Revenue, for Lung Cancer, by Region , 2021-2030,($Million)
Table 12. Interventional Oncology Market Lung Cancer by Country, 2021-2030,($Million)
Table 13. Interventional Oncology Market Revenue, for Breast Cancer, by Region , 2021-2030,($Million)
Table 14. Interventional Oncology Market Breast Cancer by Country, 2021-2030,($Million)
Table 15. Interventional Oncology Market Revenue, for Prostate Cancer, by Region , 2021-2030,($Million)
Table 16. Interventional Oncology Market Prostate Cancer by Country, 2021-2030,($Million)
Table 17. Interventional Oncology Market Revenue, for Kidney Cancer, by Region , 2021-2030,($Million)
Table 18. Interventional Oncology Market Kidney Cancer by Country, 2021-2030,($Million)
Table 19. Interventional Oncology Market Revenue, for Bone Metastasis, by Region , 2021-2030,($Million)
Table 20. Interventional Oncology Market Bone Metastasis by Country, 2021-2030,($Million)
Table 21. Interventional Oncology Market Revenue, for Other Cancers, by Region , 2021-2030,($Million)
Table 22. Interventional Oncology Market Other Cancers by Country, 2021-2030,($Million)
Table 23. Global Interventional Oncology Market, by End-user, 2021-2030,($Million)
Table 24. Interventional Oncology Market Revenue, for Hospitals, by Region , 2021-2030,($Million)
Table 25. Interventional Oncology Market Hospitals by Country, 2021-2030,($Million)
Table 26. Interventional Oncology Market Revenue, for Ambulatory Surgery Centers, by Region , 2021-2030,($Million)
Table 27. Interventional Oncology Market Ambulatory Surgery Centers by Country, 2021-2030,($Million)
Table 28. Interventional Oncology Market Revenue, for Research and Academic Institutes, by Region , 2021-2030,($Million)
Table 29. Interventional Oncology Market Research and Academic Institutes by Country, 2021-2030,($Million)
Table 30. Interventional Oncology Market, by Region, 2021-2030,($Million)
Table 31. North America Interventional Oncology Market, by Product Type, 2021-2030,($Million)
Table 32. North America Interventional Oncology Market, by Cancer Type, 2021-2030,($Million)
Table 33. North America Interventional Oncology Market, by End-user, 2021-2030,($Million)
Table 34. North America Interventional Oncology Market, by Country, 2021-2030,($Million)
Table 35. U.S. Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 36. U.S. Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 37. U.S. Interventional Oncology Market by End-user 2021-2030,($Million)
Table 38. Canada Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 39. Canada Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 40. Canada Interventional Oncology Market by End-user 2021-2030,($Million)
Table 41. Mexico Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 42. Mexico Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 43. Mexico Interventional Oncology Market by End-user 2021-2030,($Million)
Table 44. Europe Interventional Oncology Market, by Product Type, 2021-2030,($Million)
Table 45. Europe Interventional Oncology Market, by Cancer Type, 2021-2030,($Million)
Table 46. Europe Interventional Oncology Market, by End-user, 2021-2030,($Million)
Table 47. Europe Interventional Oncology Market, by Country, 2021-2030,($Million)
Table 48. Germany Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 49. Germany Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 50. Germany Interventional Oncology Market by End-user 2021-2030,($Million)
Table 51. U.K. Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 52. U.K. Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 53. U.K. Interventional Oncology Market by End-user 2021-2030,($Million)
Table 54. France Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 55. France Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 56. France Interventional Oncology Market by End-user 2021-2030,($Million)
Table 57. Spain Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 58. Spain Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 59. Spain Interventional Oncology Market by End-user 2021-2030,($Million)
Table 60. Italy Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 61. Italy Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 62. Italy Interventional Oncology Market by End-user 2021-2030,($Million)
Table 63. Rest of Europe Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 64. Rest of Europe Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 65. Rest of Europe Interventional Oncology Market by End-user 2021-2030,($Million)
Table 66. Asia-Pacific Interventional Oncology Market, by Product Type, 2021-2030,($Million)
Table 67. Asia-Pacific Interventional Oncology Market, by Cancer Type, 2021-2030,($Million)
Table 68. Asia-Pacific Interventional Oncology Market, by End-user, 2021-2030,($Million)
Table 69. Asia-Pacific Interventional Oncology Market, by Country, 2021-2030,($Million)
Table 70. China Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 71. China Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 72. China Interventional Oncology Market by End-user 2021-2030,($Million)
Table 73. Japan Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 74. Japan Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 75. Japan Interventional Oncology Market by End-user 2021-2030,($Million)
Table 76. India Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 77. India Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 78. India Interventional Oncology Market by End-user 2021-2030,($Million)
Table 79. South Korea Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 80. South Korea Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 81. South Korea Interventional Oncology Market by End-user 2021-2030,($Million)
Table 82. Australia Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 83. Australia Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 84. Australia Interventional Oncology Market by End-user 2021-2030,($Million)
Table 85. Rest of Asia-Pacific Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 86. Rest of Asia-Pacific Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 87. Rest of Asia-Pacific Interventional Oncology Market by End-user 2021-2030,($Million)
Table 88. LAMEA Interventional Oncology Market, by Product Type, 2021-2030,($Million)
Table 89. LAMEA Interventional Oncology Market, by Cancer Type, 2021-2030,($Million)
Table 90. LAMEA Interventional Oncology Market, by End-user, 2021-2030,($Million)
Table 91. LAMEA Interventional Oncology Market, by Country, 2021-2030,($Million)
Table 92. Brazil Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 93. Brazil Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 94. Brazil Interventional Oncology Market by End-user 2021-2030,($Million)
Table 95. Saudi Arabia Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 96. Saudi Arabia Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 97. Saudi Arabia Interventional Oncology Market by End-user 2021-2030,($Million)
Table 98. South Africa Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 99. South Africa Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 100. South Africa Interventional Oncology Market by End-user 2021-2030,($Million)
Table 101. Rest of LAMEA Interventional Oncology Market by Product Type 2021-2030,($Million)
Table 102. Rest of LAMEA Interventional Oncology Market by Cancer Type 2021-2030,($Million)
Table 103. Rest of LAMEA Interventional Oncology Market by End-user 2021-2030,($Million)
Table 104. Medtronic, Inc.: Company Snapshot
Table 105. Medtronic, Inc.: Operating Segments
Table 106. Medtronic, Inc.: Product Portfolio
Table 107. Medtronic, Inc.: Net Sales
Table 108. Medtronic, Inc.: Key Stratergies
Table 109. Boston Scientific Corporation: Company Snapshot
Table 110. Boston Scientific Corporation: Operating Segments
Table 111. Boston Scientific Corporation: Product Portfolio
Table 112. Boston Scientific Corporation: Net Sales
Table 113. Boston Scientific Corporation: Key Stratergies
Table 114. Bd: Company Snapshot
Table 115. Bd: Operating Segments
Table 116. Bd: Product Portfolio
Table 117. Bd: Net Sales
Table 118. Bd: Key Stratergies
Table 119. Terumo Corporation: Company Snapshot
Table 120. Terumo Corporation: Operating Segments
Table 121. Terumo Corporation: Product Portfolio
Table 122. Terumo Corporation: Net Sales
Table 123. Terumo Corporation: Key Stratergies
Table 124. Merit Medical: Company Snapshot
Table 125. Merit Medical: Operating Segments
Table 126. Merit Medical: Product Portfolio
Table 127. Merit Medical: Net Sales
Table 128. Merit Medical: Key Stratergies
Table 129. Angiodynamics: Company Snapshot
Table 130. Angiodynamics: Operating Segments
Table 131. Angiodynamics: Product Portfolio
Table 132. Angiodynamics: Net Sales
Table 133. Angiodynamics: Key Stratergies
Table 134. Johnson & Johnson: Company Snapshot
Table 135. Johnson & Johnson: Operating Segments
Table 136. Johnson & Johnson: Product Portfolio
Table 137. Johnson & Johnson: Net Sales
Table 138. Johnson & Johnson: Key Stratergies
Table 139. Teleflex Incorporated: Company Snapshot
Table 140. Teleflex Incorporated: Operating Segments
Table 141. Teleflex Incorporated: Product Portfolio
Table 142. Teleflex Incorporated: Net Sales
Table 143. Teleflex Incorporated: Key Stratergies
Table 144. Cook Group: Company Snapshot
Table 145. Cook Group: Operating Segments
Table 146. Cook Group: Product Portfolio
Table 147. Cook Group: Net Sales
Table 148. Cook Group: Key Stratergies
Table 149. Healthtronics, Inc.: Company Snapshot
Table 150. Healthtronics, Inc.: Operating Segments
Table 151. Healthtronics, Inc.: Product Portfolio
Table 152. Healthtronics, Inc.: Net Sales
Table 153. Healthtronics, Inc.: Key Stratergies
List of Figures
Figure 1. Interventional Oncology Market Segmentation
Figure 2. Interventional Oncology Market,2021-2030
Figure 3. Interventional Oncology Market,2021-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Interventional Oncology Market:Drivers, Restraints and Opportunities
Figure 12. Value Chain Analysis
Figure 13. Key Regulation Analysis
Figure 14. Market Share Analysis
Figure 15. Regulatory Guidelines
Figure 16. Interventional Oncology Market,By Product Type,2021(%)
Figure 17. Comparative Share Analysis of Embolization Devices Interventional Oncology Market,2021-2030(%)
Figure 18. Comparative Share Analysis of Ablation Devices Interventional Oncology Market,2021-2030(%)
Figure 19. Comparative Share Analysis of Support Devices Interventional Oncology Market,2021-2030(%)
Figure 20. Interventional Oncology Market,By Cancer Type,2021(%)
Figure 21. Comparative Share Analysis of Liver Cancer Interventional Oncology Market,2021-2030(%)
Figure 22. Comparative Share Analysis of Lung Cancer Interventional Oncology Market,2021-2030(%)
Figure 23. Comparative Share Analysis of Breast Cancer Interventional Oncology Market,2021-2030(%)
Figure 24. Comparative Share Analysis of Prostate Cancer Interventional Oncology Market,2021-2030(%)
Figure 25. Comparative Share Analysis of Kidney Cancer Interventional Oncology Market,2021-2030(%)
Figure 26. Comparative Share Analysis of Bone Metastasis Interventional Oncology Market,2021-2030(%)
Figure 27. Comparative Share Analysis of Other Cancers Interventional Oncology Market,2021-2030(%)
Figure 28. Interventional Oncology Market,By End-user,2021(%)
Figure 29. Comparative Share Analysis of Hospitals Interventional Oncology Market,2021-2030(%)
Figure 30. Comparative Share Analysis of Ambulatory Surgery Centers Interventional Oncology Market,2021-2030(%)
Figure 31. Comparative Share Analysis of Research and Academic Institutes Interventional Oncology Market,2021-2030(%)
Figure 32. Interventional Oncology Market by Region,2021
Figure 33. U.S. Interventional Oncology Market,2021-2030($Million)
Figure 34. Canada Interventional Oncology Market,2021-2030($Million)
Figure 35. Mexico Interventional Oncology Market,2021-2030($Million)
Figure 36. Germany Interventional Oncology Market,2021-2030($Million)
Figure 37. U.K. Interventional Oncology Market,2021-2030($Million)
Figure 38. France Interventional Oncology Market,2021-2030($Million)
Figure 39. Spain Interventional Oncology Market,2021-2030($Million)
Figure 40. Italy Interventional Oncology Market,2021-2030($Million)
Figure 41. Rest of Europe Interventional Oncology Market,2021-2030($Million)
Figure 42. China Interventional Oncology Market,2021-2030($Million)
Figure 43. Japan Interventional Oncology Market,2021-2030($Million)
Figure 44. India Interventional Oncology Market,2021-2030($Million)
Figure 45. South Korea Interventional Oncology Market,2021-2030($Million)
Figure 46. Australia Interventional Oncology Market,2021-2030($Million)
Figure 47. Rest of Asia-Pacific Interventional Oncology Market,2021-2030($Million)
Figure 48. Brazil Interventional Oncology Market,2021-2030($Million)
Figure 49. Saudi Arabia Interventional Oncology Market,2021-2030($Million)
Figure 50. South Africa Interventional Oncology Market,2021-2030($Million)
Figure 51. Rest of LAMEA Interventional Oncology Market,2021-2030($Million)
Figure 52. Top Winning Strategies, by Year
Figure 53. Top Winning Strategies, by Development
Figure 54. Top Winning Strategies, by Company
Figure 55. Product Mapping of Top 10 Players
Figure 56. Competitive Dashboard
Figure 57. Competitive Heatmap of Top 10 Key Players
Figure 58. Medtronic, Inc..: Net Sales ,($Million)
Figure 59. Boston Scientific Corporation.: Net Sales ,($Million)
Figure 60. Bd.: Net Sales ,($Million)
Figure 61. Terumo Corporation.: Net Sales ,($Million)
Figure 62. Merit Medical.: Net Sales ,($Million)
Figure 63. Angiodynamics.: Net Sales ,($Million)
Figure 64. Johnson & Johnson.: Net Sales ,($Million)
Figure 65. Teleflex Incorporated.: Net Sales ,($Million)
Figure 66. Cook Group.: Net Sales ,($Million)
Figure 67. Healthtronics, Inc..: Net Sales ,($Million)